Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses.
about
Big Data Offers Novel Insights for Oncolytic Virus ImmunotherapyNatural Killer Cell Recognition of Melanoma: New Clues for a More Effective ImmunotherapyEvidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Choice and Design of Adjuvants for Parenteral and Mucosal VaccinesMetronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistanceTrial Watch-Oncolytic viruses and cancer therapyOncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future PerspectivesSerum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.Toll-like Receptors in the Vascular System: Sensing the Dangers Within.Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatmentImmunomonitoring in glioma immunotherapy: current status and future perspectives.Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis.Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy.
P2860
Q26767209-7FBB87CB-ED9E-4F48-BD84-DC7A24604EAFQ26771449-175A1FA9-282A-49D3-9A83-EC78AEEB6D0FQ26775030-66FE01B4-7EC3-452C-A84B-7A8461AB61F6Q26783488-37BDBAFF-27FC-437D-B5FA-CC6056A342DAQ27023579-5FA4750B-D9B5-4EB7-B86C-50CFF3F571FAQ28072347-D8DB6F25-516F-4095-8A00-742FC5EF9BF5Q33679505-EC0988C8-F88D-4E83-9B82-D98516E9F7B2Q35506253-11C0A2CC-CCCB-4B41-A02B-CCA5BB9CD53DQ36453194-70905170-644D-42E3-B77D-BDAE6374BB05Q37114367-ACC18AD2-A8AA-422D-8544-3CB967BA202DQ37702075-20A2EF8E-CD44-49E9-A042-FD1775A1059AQ38659771-37BDF1D7-93FF-40DC-83B5-7AD7522904B4Q39004691-F33AF237-1619-4533-BFC9-E14D098B36F4Q39868041-5FDBF383-7416-4B95-BB77-8BC32806C8B8
P2860
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immunoglobulin-like transcript ...... therapy with vaccinia viruses.
@ast
Immunoglobulin-like transcript ...... therapy with vaccinia viruses.
@en
type
label
Immunoglobulin-like transcript ...... therapy with vaccinia viruses.
@ast
Immunoglobulin-like transcript ...... therapy with vaccinia viruses.
@en
prefLabel
Immunoglobulin-like transcript ...... therapy with vaccinia viruses.
@ast
Immunoglobulin-like transcript ...... therapy with vaccinia viruses.
@en
P2093
P2860
P921
P356
P1476
Immunoglobulin-like transcript ...... therapy with vaccinia viruses.
@en
P2093
Dae Won Kim
Francesco M Marincola
Howard L Kaufman
Michael C Jagoda
Seunghee Kim-Schulze
Vladia Monsurro
P2860
P2888
P356
10.1186/2051-1426-2-1
P50
P577
2014-01-27T00:00:00Z
P5875
P6179
1030013400